Clinical Trial Update: Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) [Phase 3]

View source ↗

Summary

Clinical trial comparing elacytarabine to investigator's choice in late-stage acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Elacytarabine

Snippet

Sponsor: Clavis Pharma | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: COMPLETED